Lanean...
Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...
Gorde:
Egile Nagusiak: | , , , , , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
S. Karger AG
2011
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3082484/ https://ncbi.nlm.nih.gov/pubmed/21526001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000323804 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|